These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 29217369

  • 1. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.
    Parker EPK, Praharaj I, Zekavati A, Lazarus RP, Giri S, Operario DJ, Liu J, Houpt E, Iturriza-Gómara M, Kampmann B, John J, Kang G, Grassly NC.
    Vaccine; 2018 Jan 04; 36(2):264-272. PubMed ID: 29217369
    [Abstract] [Full Text] [Related]

  • 2. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants.
    Parker EPK, Bronowski C, Sindhu KNC, Babji S, Benny B, Carmona-Vicente N, Chasweka N, Chinyama E, Cunliffe NA, Dube Q, Giri S, Grassly NC, Gunasekaran A, Howarth D, Immanuel S, Jere KC, Kampmann B, Lowe J, Mandolo J, Praharaj I, Rani BS, Silas S, Srinivasan VK, Turner M, Venugopal S, Verghese VP, Darby AC, Kang G, Iturriza-Gómara M.
    Nat Commun; 2021 Dec 15; 12(1):7288. PubMed ID: 34911947
    [Abstract] [Full Text] [Related]

  • 3. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
    Bautista-Marquez A, Velasquez DE, Esparza-Aguilar M, Luna-Cruz M, Ruiz-Moran T, Sugata K, Jiang B, Parashar U, Patel M, Richardson V.
    Vaccine; 2016 Oct 17; 34(44):5284-5289. PubMed ID: 27663670
    [Abstract] [Full Text] [Related]

  • 4. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.
    Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, Babji S, Sarkar R, Kaliappan PS, Venugopal S, Praharaj I, Raman U, Paranjpe M, Grassly NC, Parker EPK, Parashar UD, Tate JE, Fleming JA, Steele AD, Muliyil J, Abraham AM, Kang G.
    Vaccine; 2018 Jan 04; 36(2):273-279. PubMed ID: 28874323
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
    Kompithra RZ, Paul A, Manoharan D, Babji S, Sarkar R, Mathew LG, Kang G.
    Vaccine; 2014 Aug 11; 32 Suppl 1():A129-33. PubMed ID: 25091666
    [Abstract] [Full Text] [Related]

  • 6. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
    Emperador DM, Velasquez DE, Estivariz CF, Lopman B, Jiang B, Parashar U, Anand A, Zaman K.
    Clin Infect Dis; 2016 Jan 15; 62(2):150-6. PubMed ID: 26349548
    [Abstract] [Full Text] [Related]

  • 7. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.
    Harris V, Ali A, Fuentes S, Korpela K, Kazi M, Tate J, Parashar U, Wiersinga WJ, Giaquinto C, de Weerth C, de Vos WM.
    Gut Microbes; 2018 Mar 04; 9(2):93-101. PubMed ID: 28891751
    [Abstract] [Full Text] [Related]

  • 8. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
    Dang DA, Nguyen VT, Vu DT, Nguyen TH, Nguyen DM, Yuhuan W, Baoming J, Nguyen DH, Le TL, Rotavin-M1 Vaccine Trial Group.
    Vaccine; 2012 Apr 27; 30 Suppl 1():A114-21. PubMed ID: 22520120
    [Abstract] [Full Text] [Related]

  • 9. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
    Ella R, Babji S, Ciarlet M, Blackwelder WC, Vadrevu KM.
    Vaccine; 2019 Jul 18; 37(31):4407-4413. PubMed ID: 31178377
    [Abstract] [Full Text] [Related]

  • 10. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Lee B, Dickson DM, Alam M, Afreen S, Kader A, Afrin F, Ferdousi T, Damon CF, Gullickson SK, McNeal MM, Bak DM, Tolba M, Carmolli MP, Taniuchi M, Haque R, Kirkpatrick BD.
    Vaccine; 2020 Jan 03; 38(1):90-99. PubMed ID: 31607603
    [Abstract] [Full Text] [Related]

  • 11. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.
    Patel M, Steele AD, Parashar UD.
    Vaccine; 2012 Apr 27; 30 Suppl 1():A30-5. PubMed ID: 22520134
    [Abstract] [Full Text] [Related]

  • 12. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana.
    Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, Lewis KD, de Vos WM.
    J Infect Dis; 2017 Jan 01; 215(1):34-41. PubMed ID: 27803175
    [Abstract] [Full Text] [Related]

  • 13. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T, Palkar S, Misra P, Gupta M, Venugopal P, Sood AK, Dhati RM, Shetty A, Dhaded SM, Agarkhedkar S, Choudhury A, Kumar R, Balasubramanian S, Babji S, Adhikary L, Dupuy M, Chadha SM, Desai F, Kukian D, Patnaik BN, Dhingra MS.
    Vaccine; 2017 Jun 16; 35(28):3575-3581. PubMed ID: 28536027
    [Abstract] [Full Text] [Related]

  • 14. Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial.
    Rongsen-Chandola T, Winje BA, Goyal N, Rathore SS, Mahesh M, Ranjan R, Arya A, Rafiqi FA, Bhandari N, Strand TA.
    Trials; 2014 Jun 28; 15():256. PubMed ID: 24976452
    [Abstract] [Full Text] [Related]

  • 15. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
    Baker JM, Tate JE, Leon J, Haber MJ, Lopman BA.
    PLoS Med; 2019 Dec 28; 16(12):e1003005. PubMed ID: 31887139
    [Abstract] [Full Text] [Related]

  • 16. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.
    Ella R, Bobba R, Muralidhar S, Babji S, Vadrevu KM, Bhan MK.
    Hum Vaccin Immunother; 2018 Jul 03; 14(7):1791-1799. PubMed ID: 29543547
    [Abstract] [Full Text] [Related]

  • 17. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D, Boniface K, Bogdanovic-Sakran N, Kirkwood CD, Bines JE.
    Hum Vaccin Immunother; 2017 Aug 03; 13(8):1908-1915. PubMed ID: 28481726
    [Abstract] [Full Text] [Related]

  • 18. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS, Groome MJ, Velasquez DE, Parashar UD, Jones S, Koen A, van Niekerk N, Jiang B, Madhi SA.
    Clin Infect Dis; 2016 Jan 15; 62(2):157-65. PubMed ID: 26400993
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study.
    Gillard P, Tamura T, Kuroki H, Morikawa Y, Moerman L, Parra J, Kitamura Y, Mihara K, Okamasa A.
    Hum Vaccin Immunother; 2019 Jan 15; 15(4):800-808. PubMed ID: 30785851
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
    Shin S, Anh DD, Zaman K, Yunus M, Mai le TP, Thiem VD, Azim T, Victor JC, Dallas MJ, Steele AD, Neuzil KM, Ciarlet M.
    Vaccine; 2012 Apr 27; 30 Suppl 1():A106-13. PubMed ID: 22520119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.